A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia

NCT01886053 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Community Acquired Pneumonia

Interventions

DRUG: Faropenem（high dose group）
DRUG: Faropenem（low-dose group)
DRUG: Ertapenem

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.